Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration

Brigitte Michelsen* (Corresponding Author), Ulf Lindström, Catalin Codreanu, Adrian Ciurea, Jakub Zavada, Anne Gitte Loft, Manuel Pombo-Suarez, Fatos Onen, Tore K Kvien, Ziga Rotar, Maria Jose Santos, Florenzo Iannone, Anna-Mari Hokkanen, Bjorn Gudbjornsson, Johan Askling, Ruxandra Ionescu, Michael J Nissen, Karel Pavelka, Carlos Sanchez-Piedra, Servet AkarJoseph Sexton, Matija Tomsic, Helena Santos, Marco Sebastiani, Jenny Österlund, Arni Jon Geirsson, Gary Macfarlane, Irene van der Horst-Bruinsma, Stylianos Georgiadis, Cecilie Heegaard Brahe, Lykke Midtbøll Ørnbjerg, Merete Lund Hetland, Mikkel Østergaard

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration'. Together they form a unique fingerprint.

Medicine & Life Sciences